These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4151692

  • 21. Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock.
    Puri PS, Bing RJ.
    Am Heart J; 1969 Nov; 78(5):660-8. PubMed ID: 5348748
    [No Abstract] [Full Text] [Related]

  • 22. [Use of glucagon in the treatment of severe contractile insufficiency of the myocardium].
    Bertolazzi R, Ricciardi S, Marenco G.
    Minerva Med; 1976 Nov 10; 67(54):3519-24. PubMed ID: 995299
    [Abstract] [Full Text] [Related]

  • 23. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J, Oilinki O, Huhti E, Vuopala U, Koivisto O.
    Acta Med Scand; 1972 Sep 10; 192(3):165-70. PubMed ID: 5055261
    [No Abstract] [Full Text] [Related]

  • 24. [Cardiac action of glucagon in patients with heart diseases].
    Hermann HJ, Sanmarco ME, Meyers SN.
    Prensa Med Argent; 1971 Jul 10; 58(22):1079-85. PubMed ID: 5097750
    [No Abstract] [Full Text] [Related]

  • 25. Glucagon: a new agent for the treatment of low cardiac output syndromes.
    Kones RJ.
    Jpn Heart J; 1972 May 10; 13(3):266-71. PubMed ID: 4538258
    [No Abstract] [Full Text] [Related]

  • 26. Drug therapy in cardiogenic shock.
    Ramdohr B.
    Int J Clin Pharmacol; 1973 Apr 10; 7(2):118-26. PubMed ID: 4731279
    [No Abstract] [Full Text] [Related]

  • 27. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock.
    Cole JB, Stellpflug SJ, Ellsworth H, Anderson CP, Adams AB, Engebretsen KM, Holger JS.
    Clin Toxicol (Phila); 2013 May 10; 51(4):201-7. PubMed ID: 23530460
    [Abstract] [Full Text] [Related]

  • 28. [Glucagon in the acute stage of myocardial infarct].
    Waremboug H, Bertrand ME, Ducloux G, Pauchant M, Ginestet A, Ketelers JY, Carre A, Delbecque H.
    Arch Mal Coeur Vaiss; 1973 Apr 10; 66(4):449-56. PubMed ID: 4200209
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of irreversible heart decompensation and cardiogenic shock with glucagon].
    Bruni B.
    Minerva Cardioangiol; 1972 Apr 10; 20(7):419-27. PubMed ID: 5050748
    [No Abstract] [Full Text] [Related]

  • 30. [The importance of glucagon in cardiology].
    Simon H.
    Schweiz Rundsch Med Prax; 1972 Jan 10; 61(2):31-3. PubMed ID: 5011863
    [No Abstract] [Full Text] [Related]

  • 31. Effects of glucagon on myocardial contractility and cardiac output.
    Hamer J, Gibson D, Coltart J.
    Br Heart J; 1972 Feb 10; 34(2):204. PubMed ID: 5007807
    [No Abstract] [Full Text] [Related]

  • 32. [Cardiovascular effects of glucagon].
    Liakishev AA, Golikov AP.
    Kardiologiia; 1972 Jul 10; 12(7):128-36. PubMed ID: 4364203
    [No Abstract] [Full Text] [Related]

  • 33. [Studies on the cardiac effect of glucagon in patients with chronic failure of left ventricle (author's transl)].
    Kuhn H, Jaeschke M, Breithardt G, Loogen F.
    Z Kardiol; 1978 Apr 10; 67(4):256-64. PubMed ID: 207029
    [No Abstract] [Full Text] [Related]

  • 34. [Glucagon, its general and local action].
    Nikolov NA, Abud FA, Sirakova IA.
    Usp Fiziol Nauk; 1979 Apr 10; 10(4):23-51. PubMed ID: 230660
    [No Abstract] [Full Text] [Related]

  • 35. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W, Günther K, Trenckmann H, Döring D.
    Z Gesamte Inn Med; 1970 Apr 01; 25(7):290-3. PubMed ID: 4398843
    [No Abstract] [Full Text] [Related]

  • 36. Glucagon in resistant heart-failure and cardiogenic shock.
    Wilcken DE, Lvoff R.
    Lancet; 1970 Jun 20; 760(1):1315-8. PubMed ID: 4193948
    [No Abstract] [Full Text] [Related]

  • 37. Newer inotropic agents for cardiogenic shock.
    Kones RJ, Phillips JH.
    South Med J; 1972 Mar 20; 65(3):329-32. PubMed ID: 5016450
    [No Abstract] [Full Text] [Related]

  • 38. The treatment of shock with beta adrenergic blockade.
    Berk JL, Hagen JF, Maly G, Koo R.
    Arch Surg; 1972 Jan 20; 104(1):46-51. PubMed ID: 4399892
    [No Abstract] [Full Text] [Related]

  • 39. [Experimental and clinical studies on effects of glucagon on the ischmic heart].
    Asai Y.
    Nihon Kyobu Geka Gakkai Zasshi; 1974 Dec 20; 22(12):1158-71. PubMed ID: 4477168
    [No Abstract] [Full Text] [Related]

  • 40. [Glucagon--a therapeutic alternative in heart failure?].
    Andersen HT.
    Nord Med; 1971 Nov 25; 86(47):1369-75. PubMed ID: 4333034
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.